Motor neuron diversity in development and disease

Annual Review of Neuroscience

Volumn 33, Issue , 2010, Pages 409-440

  Kanning, Kevin C ^a   Kaplan, Artem ^a   Henderson, Christopher E ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

amyotrophic lateral sclerosis (ALS); axonal degeneration; motor pool; motor unit; neuromuscular junction; spinal muscular atrophy (SMA)

Indexed keywords

CARDIOTROPHIN 1; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; MOLECULAR MARKER; NEUROTROPHIC FACTOR; PROTEIN BCL 2; SALUBRINAL; SMOOTH MUSCLE ACTIN; SOMATOMEDIN C; VASCULOTROPIN;

AGING; ALPHA NERVE FIBER; AMYOTROPHIC LATERAL SCLEROSIS; BEHAVIOR; CELL SIZE; CELL STRUCTURE; CELL SURVIVAL; DISEASE COURSE; EYE MOVEMENT; GAMMA MOTONEURON; HUMAN; MOTONEURON; MOTOR NEURON DISEASE; MOTOR UNIT; NERVE CELL NECROSIS; NERVE DEGENERATION; NERVE FIBER DEGENERATION; NERVE FIBER GROWTH; NERVE POTENTIAL; NEUROPATHY; NONHUMAN; PRIORITY JOURNAL; REVIEW; SKELETAL MUSCLE; SPINAL CORD MOTONEURON; SPINAL MUSCULAR ATROPHY; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; CELL DIFFERENTIATION; HUMANS; MOTOR NEURON DISEASE; MOTOR NEURONS;

EID: 77954103868     PISSN: 0147006X     EISSN: 15454126     Source Type: Book Series    
DOI: 10.1146/annurev.neuro.051508.135722     Document Type: Review

References (191)

1. Acsadi G, Anguelov RA, Yang H, Toth G, Thomas R, et al. 2002. Increased survival and function of SOD1 mice after glial cell-derived neurotrophic factor gene therapy. Hum. Gene Ther. 13:1047-1059
2. Alexianu ME, Ho BK, Mohamed AH, La Bella V, Smith RG, Appel SH. 1994. The role of calcium-binding proteins in selective motoneuron vulnerability in amyotrophic lateral sclerosis. Ann. Neurol. 36:846-858
3. Askanas V, Engel WK, Alvarez RB. 1992. Strong immunoreactivity of beta-amyloid precursor protein, including the beta-amyloid protein sequence, at human neuromuscular junctions. Neurosci. Lett. 143:96-100
4. Atkin JD, Farg MA, Turner BJ, Tomas D, Lysaght JA, et al. 2006. Induction of the unfolded protein response in familial amyotrophic lateral sclerosis and association of protein-disulfide isomerase with superoxide dismutase 1. J. Biol. Chem. 281:30152-30165
5. Atkin JD, Farg MA,Walker AK, McLean C, Tomas D, Horne MK. 2008. Endoplasmic reticulum stress and induction of the unfolded protein response in human sporadic amyotrophic lateral sclerosis. Neurobiol. Dis. 30:400-407
6. Azzouz M, Ralph GS, Storkebaum E, Walmsley LE, Mitrophanous KA, et al. 2004. VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model. Nature 429:413-417
7. Bakels R, Kernell D. 1993. Matching between motoneurone and muscle unit properties in rat medial gastrocnemius. J. Physiol. 463:307-324
8. Beers DR, Ho BK, Siklos L, Alexianu ME, Mosier DR, et al. 2001. Parvalbumin overexpression alters immunemediated increases in intracellular calcium, and delays disease onset in a transgenic model of familial amyotrophic lateral sclerosis. J. Neurochem. 79:499-509
9. Bendotti C, Calvaresi N, Chiveri L, Prelle A, Moggio M, et al. 2001. Early vacuolization and mitochondrial damage in motor neurons of FALS mice are not associated with apoptosis or with changes in cytochrome oxidase histochemical reactivity. J. Neurol. Sci. 191:25-33
10. Boillee S, Cleveland DW. 2004. Gene therapy for ALS delivers. Trends Neurosci. 27:235-238
11. Boillee S, Vande Velde C, Cleveland DW. 2006. ALS: a disease of motor neurons and their nonneuronal neighbors. Neuron 52:39-59
12. Bordet T, Lesbordes JC, Rouhani S, Castelnau-Ptakhine L, Schmalbruch H, et al. 2001. Protective effects of cardiotrophin-1 adenoviral gene transfer on neuromuscular degeneration in transgenic ALS mice. Hum. Mol. Genet. 10:1925-1933
13. Boyce M, Bryant KF, Jousse C, Long K, Harding HP, et al. 2005. A selective inhibitor of eIF2alpha dephosphorylation protects cells from ER stress. Science 307:935-939
14. Burke RE. 1980. Motor unit types: functional specializations in motor control. Trends Neurosci. 3:255-258
15. Burke RE, Levine DN, Tsairis P, Zajac FE 3rd. 1973. Physiological types and histochemical profiles in motor units of the cat gastrocnemius. J. Physiol. 234:723-748
16. Burke RE, Strick PL, Kanda K, Kim CC, Walmsley B. 1977. Anatomy of medial gastrocnemius and soleus motor nuclei in cat spinal cord. J. Neurophysiol. 40:667-680
17. Buss RR, Gould TW, Ma J, Vinsant S, Prevette D, et al. 2006. Neuromuscular development in the absence of programmed cell death: phenotypic alteration of motoneurons and muscle. J. Neurosci. 26:13413-13427
18. Chakkalakal J, Nishimune H, Sanes JR. 2008. The synaptic vesicle protein SV2A selectively marks slow neuromuscular junctions and motor units. Progr.No. 859.1. 2008 Neuroscience Meeting Planner.Washington, DC: Soc. Neurosci. http://www.sfn.org/am2008/
19. Cheroni C, Marino M, Tortarolo M, Veglianese P, De Biasi S, et al. 2009. Functional alterations of the ubiquitin-proteasome system in motor neurons of amousemodel of familial amyotrophic lateral sclerosis. Hum. Mol. Genet. 18:82-96
20. Chiu AY, Zhai P, Dal Canto MC, Peters TM, Kwon YW, et al. 1995. Age-dependent penetrance of disease in a transgenic mouse model of familial amyotrophic lateral sclerosis. Mol. Cell Neurosci. 6:349-362
21. Cleveland DW, Rothstein JD. 2001. From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS. Nat. Rev. Neurosci. 2:806-819
22. Cnop M, Ladriere L, Hekerman P, Ortis F, Cardozo AK, et al. 2007. Selective inhibition of eukaryotic translation initiation factor 2 alpha dephosphorylation potentiates fatty acid-induced endoplasmic reticulum stress and causes pancreatic beta-cell dysfunction and apoptosis. J. Biol. Chem. 282:3989-3997
23. Cullheim S, Fleshman JW, Glenn LL, Burke RE. 1987. Membrane area and dendritic structure in typeidentified triceps surae alpha motoneurons. J. Comp. Neurol. 255:68-81
24. Dalla Torre di Sanguinetto SA, Dasen JS, Arber S. 2008. Transcriptional mechanisms controlling motor neuron diversity and connectivity. Curr. Opin. Neurobiol. 18:36-43
25. Dasen JS, Jessell TM. 2009. Hox networks and the origins of motor neuron diversity. Curr. Top. Dev. Biol. 88:169-200
26. David G, Nguyen K, Barrett EF. 2007. Early vulnerability to ischemia/reperfusion injury in motor terminals innervating fast muscles of SOD1-G93A mice. Exp. Neurol. 204:411-420
27. Davies AM. 1996. The neurotrophic hypothesis: Where does it stand? Philos. Trans. R. Soc. Lond. B Biol. Sci. 351:389-394
28. de CarvalhoMA, Pinto S, Swash M. 2008. Paraspinal and limbmotor neuron involvement within homologous spinal segments in ALS. Clin. Neurophysiol. 119:1607-1613
29. Deckwerth TL, Elliott JL, Knudson CM, Johnson EM Jr, SniderWD, Korsmeyer SJ. 1996. BAX is required for neuronal death after trophic factor deprivation and during development. Neuron 17:401-411
30. Dengler R, Konstanzer A, Kuther G, Hesse S, Wolf W, Struppler A. 1990. Amyotrophic lateral sclerosis: macro-EMG and twitch forces of single motor units. Muscle Nerve 13:545-550
31. Derouet D,Rousseau F, Alfonsi F, Froger J,Hermann J, et al. 2004. Neuropoietin, a new IL-6-related cytokine signaling through the ciliary neurotrophic factor receptor. Proc. Natl. Acad. Sci. USA 101:4827-4832
32. De Vos KJ, Chapman AL, Tennant ME, Manser C, Tudor EL, et al. 2007. Familial amyotrophic lateral sclerosis-linked SOD1 mutants perturb fast axonal transport to reduce axonal mitochondria content. Hum. Mol. Genet. 16:2720-2728
33. De Winter F, Vo T, Stam FJ, Wisman LA, Bar PR, et al. 2006. The expression of the chemorepellent Semaphorin 3A is selectively induced in terminal Schwann cells of a subset of neuromuscular synapses that display limited anatomical plasticity and enhanced vulnerability in motor neuron disease. Mol. Cell Neurosci. 32:102-117
34. DobretsovM,Hastings SL, Sims TJ, Stimers JR, RomanovskyD. 2003. Stretch receptor-associated expression of alpha 3 isoform of the Na+, K+-ATPase in rat peripheral nervous system. Neuroscience 116:1069-1080
35. Dubowitz V. 1978. Muscle disorders in childhood. Major Probl. Clin. Pediatr. 16:iii-xiii, 1-282
36. Duchen LW, Tonge DA. 1973. The effects of tetanus toxin on neuromuscular transmission and on the morphology of motor end-plates in slow and fast skeletal muscle of the mouse. J. Physiol. 228:157-172
37. Duplan L, Bernard N, Casseron WD, Dudley K, Thouvenot E, et al. 2010. Collapsin response mediator protein 4a (CRMP4a) is upregulated in motoneurons of mutant SOD1 mice and can trigger motoneuron death. J. Neurosci. 30:785-796
38. Eccles JC, Eccles RM, Iggo A, Lundberg A. 1960. Electrophysiological studies on gamma motoneurones. Acta Physiol. Scand. 50:32-40
39. Eccles JC, Eccles RM, Lundberg A. 1957. Durations of after- hyperpolarization of motoneurones supplying fast and slow muscles. Nature 179:866-868
40. Elson GC, Lelievre E, Guillet C, Chevalier S, Plun-Favreau H, et al. 2000. CLF associates with CLC to form a functional heteromeric ligand for the CNTF receptor complex. Nat. Neurosci. 3:867-872
41. Ferrucci M, Spalloni A, Bartalucci A, Cantafora E, Fulceri F, et al. 2010. A systematic study of brainstem motor nuclei in a mouse model of ALS, the effects of lithium. Neurobiol. Dis. 37:370-383
42. Fischer LR, Culver DG, Tennant P, Davis AA, Wang M, et al. 2004. Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man. Exp. Neurol. 185:232-240
43. Forger NG, Prevette D, deLapeyriere O, de Bovis B, Wang S, et al. 2003. Cardiotrophin-like cytokine/cytokine-like factor 1 is an essential trophic factor for lumbar and facial motoneurons in vivo. J. Neurosci. 23:8854-8858
44. Frey D, Schneider C, Xu L, Borg J, Spooren W, Caroni P. 2000. Early and selective loss of neuromuscular synapse subtypes with low sprouting competence in motoneuron diseases. J. Neurosci. 20:2534-2542
45. Friese A, Kaltschmidt JA, Ladle DR, Sigrist M, Jessell TM, Arber S. 2009. Gamma and alpha motor neurons distinguished by expression of transcription factor Err3. Proc. Natl. Acad. Sci. USA 106:13588-13593
46. Galluzzi L, Blomgren K, Kroemer G. 2009. Mitochondrial membrane permeabilization in neuronal injury. Nat. Rev. Neurosci. 10:481-494
47. Garces A, Haase G, Airaksinen MS, Livet J, Filippi P, deLapeyriere O. 2000. GFRalpha 1 is required for development of distinct subpopulations of motoneuron. J. Neurosci. 20:4992-5000
48. Gardiner PF. 1993. Physiological properties of motoneurons innervating different muscle unit types in rat gastrocnemius. J. Neurophysiol. 69:1160-1170
49. Gizzi M, DiRocco A, Sivak M, Cohen B. 1992. Ocular motor function in motor neuron disease. Neurology 42:1037-1046
50. Gordon DC, Loeb GE, Richmond FJ. 1991. Distribution of motoneurons supplying cat sartorius and tensor fasciae latae, demonstrated by retrograde multiple-labeling methods. J. Comp. Neurol. 304:357-372
51. Gordon T, Tyreman N, Li S, Putman CT, Hegedus J. 2010. Functional overload saves motor units in the SOD1-G93A transgenic mouse model of amyotrophic lateral sclerosis. Neurobiol. Dis. 37:412-422
52. Gould TW, Buss RR, Vinsant S, Prevette D, Sun W, et al. 2006. Complete dissociation of motor neuron death from motor dysfunction by Bax deletion in a mouse model of ALS. J. Neurosci. 26:8774-8786
53. Gould TW, Enomoto H. 2009. Neurotrophic modulation of motor neuron development. Neuroscientist 15:105-116
54. Gould TW, Oppenheim RW.2004. The function of neurotrophic factor receptors expressed by the developing adductor motor pool in vivo. J. Neurosci. 24:4668-4682
55. Gould TW,Yonemura S, OppenheimRW,Ohmori S,Enomoto H. 2008. The neurotrophic effects of glial cell line-derived neurotrophic factor on spinal motoneurons are restricted to fusimotor subtypes. J. Neurosci. 28:2131-2146
56. Guegan C, Przedborski S. 2003. Programmed cell death in amyotrophic lateral sclerosis. J. Clin. Invest. 111:153-161
57. Haase G, Dessaud E, Garces A, de Bovis B, Birling M, et al. 2002. GDNF acts through PEA3 to regulate cell body positioning and muscle innervation of specific motor neuron pools. Neuron 35:893-905
58. Haase G, Pettmann B, Raoul C, Henderson CE. 2008. Signaling by death receptors in the nervous system. Curr. Opin. Neurobiol. 18:284-291
59. Hashizume K, Kanda K, Burke RE. 1988. Medial gastrocnemiusmotor nucleus in the rat: age-related changes in the number and size of motoneurons. J. Comp. Neurol. 269:425-430
60. Heckman CJ, Johnson M, Mottram C, Schuster J. 2008. Persistent inward currents in spinal motoneurons and their influence on human motoneuron firing patterns. Neuroscientist 14:264-275
61. Hegedus J, Putman CT, Gordon T. 2007. Time course of preferential motor unit loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis. Neurobiol. Dis. 28:154-164
62. Hegedus J, Putman CT, Tyreman N, Gordon T. 2008. Preferential motor unit loss in the SOD1 G93A transgenic mouse model of amyotrophic lateral sclerosis. J. Physiol. 586:3337-3351
63. Helmbacher F, Dessaud E, Arber S, deLapeyriere O, Henderson CE, et al. 2003. Met signaling is required for recruitment of motor neurons to PEA3-positive motor pools. Neuron 39:767-777
64. Helmbacher F, Schneider-Maunoury S,Topilko P,Tiret L, Charnay P. 2000. Targeting of the EphA4 tyrosine kinase receptor affects dorsal/ventral pathfinding of limb motor axons. Development 127:3313-3324
65. Henderson CE. 1995. Neurotrophic factors as therapeutic agents in amyotrophic lateral sclerosis. Potential and pitfalls. Adv. Neurol. 68:235-240
66. Henderson CE. 1996. Role of neurotrophic factors in neuronal development. Curr. Opin. Neurobiol. 6:64-70
67. Henderson CE, PhillipsHS, Pollock RA,Davies AM, Lemeulle C, et al. 1994. GDNF: a potent survival factor for motoneurons present in peripheral nerve and muscle. Science 266:1062-1064
68. Hirofuji C, Ishihara A, Roy RR, Itoh K, Itoh M, et al. 2000. SDH activity and cell size of tibialis anterior motoneurons and muscle fibers in SAMP6. Neuroreport 11:823-828
69. Holtmann B, Wiese S, SamsamM,GrohmannK, Pennica D, et al. 2005. Triple knock-out of CNTF, LIF, and CT-1 defines cooperative and distinct roles of these neurotrophic factors for motoneuron maintenance and function. J. Neurosci. 25:1778-1787
70. Hoover JE, Durkovic RG. 1991. Morphological relationships among extensor digitorum longus, tibialis anterior, and semitendinosus motor nuclei of the cat: an investigation employing the retrograde transport of multiple fluorescent tracers. J. Comp. Neurol. 303:255-266
71. Horcholle-BossavitG, JamiL,ThiessonD,ZytnickiD. 1990. Postnatal development of peronealmotoneurons in the kitten. Brain Res. Dev. Brain Res. 54:205-215
72. Howe CL, Bergstrom RA, Horazdovsky BF. 2009. Subcutaneous IGF-1 is not beneficial in 2-year ALS trial. Neurology 73:1247; author reply p. 1248
73. Hui K, Kucera J, Henderson JT. 2008. Differential sensitivity of skeletal and fusimotor neurons to Bcl-2- mediated apoptosis during neuromuscular development. Cell Death Differ. 15:691-699
74. Hunt CC, Kuffler SW. 1951. Further study of efferent small-nerve fibers to mammalian muscle spindles; multiple spindle innervation and activity during contraction. J. Physiol. 113:283-297
75. Iwata M, Hirano A. 1978. Sparing of the Onufrowicz nucleus in sacral anterior horn lesions. Ann. Neurol. 4:245-249
76. Jokic N, Gonzalez de Aguilar JL, Dimou L, Lin S, Fergani A, et al. 2006. The neurite outgrowth inhibitor Nogo-A promotes denervation in an amyotrophic lateral sclerosis model. EMBO Rep. 7:1162-1167
77. Jokic N, Gonzalez de Aguilar JL, Pradat PF, Dupuis L, Echaniz-Laguna A, et al. 2005. Nogo expression in muscle correlates with amyotrophic lateral sclerosis severity. Ann. Neurol. 57:553-556
78. Kadhiresan VA, Hassett CA, Faulkner JA. 1996. Properties of single motor units in medial gastrocnemius muscles of adult and old rats. J. Physiol. 493(Pt. 2):543-552
79. Kaminski HJ, Richmonds CR, Kusner LL, MitsumotoH. 2002. Differential susceptibility of the ocular motor system to disease. Ann. N. Y. Acad. Sci. 956:42-54
80. Kanda K, Hashizume K. 1989. Changes in properties of the medial gastrocnemius motor units in aging rats. J. Neurophysiol. 61:737-746
81. Kania A, Jessell TM. 2003. Topographicmotor projections in the limb imposed by LIM homeodomain protein regulation of ephrin-A:EphA interactions. Neuron 38:581-596
82. Kanungo AK, Hao Z, Elia AJ, Mak TW, Henderson JT. 2008. Inhibition of apoptosome activation protects injured motor neurons from cell death. J. Biol. Chem. 283:22105-22112
83. Kaspar BK, Llado J, Sherkat N, Rothstein JD, Gage FH. 2003. Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model. Science 301:839-842
84. Kato S. 2008. Amyotrophic lateral sclerosis models and human neuropathology: similarities and differences. Acta Neuropathol. 115:97-114
85. Kato T, Kurita K, Seino T, Kadoya T, Horie H, et al. 2001. Galectin-1 is a component of neurofilamentous lesions in sporadic and familial amyotrophic lateral sclerosis. Biochem. Biophys. Res. Commun. 282:166-172
86. Keller-Peck CR, Feng G, Sanes JR, Yan Q, Lichtman JW, Snider WD. 2001. Glial cell line-derived neurotrophic factor administration in postnatal life results in motor unit enlargement and continuous synaptic remodeling at the neuromuscular junction. J. Neurosci. 21:6136-6146
87. Kernell D. 2003. Principles of force gradation in skeletal muscles. Neural. Plast. 10:69-76
88. Kernell D, Bakels R, Copray JC. 1999. Discharge properties of motoneurones: How are they matched to the properties and use of their muscle units? J. Physiol. Paris 93:87-96
89. Kieran D, Hafezparast M, Bohnert S, Dick JR, Martin J, et al. 2005. A mutation in dynein rescues axonal transport defects and extends the life span of ALS mice. J. Cell Biol. 169:561-567
90. Kieran D, Sebastia J, Greenway MJ, King MA, Connaughton D, et al. 2008. Control of motoneuron survival by angiogenin. J. Neurosci. 28:14056-14061
91. Kieran D, Woods I, Villunger A, Strasser A, Prehn JH. 2007. Deletion of the BH3-only protein puma protects motoneurons from ERstress-induced apoptosis and delaysmotoneuron loss in ALS mice. Proc.Natl. Acad. Sci. USA 104:20606-20611
92. Kikuchi H, Almer G, Yamashita S, Guegan C, Nagai M, et al. 2006. Spinal cord endoplasmic reticulum stress associated with a microsomal accumulation of mutant superoxide dismutase-1 in an ALS model. Proc. Natl. Acad. Sci. USA 103:6025-6030
93. Koistinen H, Prinjha R, Soden P, Harper A, Banner SJ, et al. 2006. Elevated levels of amyloid precursor protein in muscle of patients with amyotrophic lateral sclerosis and a mouse model of the disease. Muscle Nerve 34:444-450
94. Kong J, Xu Z. 1998. Massive mitochondrial degeneration in motor neurons triggers the onset of amyotrophic lateral sclerosis in mice expressing a mutant SOD1. J. Neurosci. 18:3241-3250
95. Kostic V, Jackson-Lewis V, de Bilbao F, Dubois-Dauphin M, Przedborski S. 1997. Bcl-2: prolonging life in a transgenic mouse model of familial amyotrophic lateral sclerosis. Science 277:559-562
96. Kramer ER, Knott L, Su F, Dessaud E, Krull CE, et al. 2006. Cooperation between GDNF/Ret and ephrinA/ EphA4 signals for motor-axon pathway selection in the limb. Neuron 50:35-47
97. Kubota M, Sakakihara Y, Uchiyama Y, Nara A, Nagata T, et al. 2000.New ocular movement detector system as a communication tool in ventilator-assisted Werdnig-Hoffmann disease. Dev. Med. ChildNeurol. 42:61-64
98. Kuffler SW, Hunt CC, Quilliam JP. 1951. Function of medullated small-nerve fibers in mammalian ventral roots; efferent muscle spindle innervation. J. Neurophysiol. 14:29-54
99. Kuo JJ, Schonewille M, Siddique T, Schults AN, Fu R, et al. 2004. Hyperexcitability of cultured spinal motoneurons from presymptomatic ALS mice. J. Neurophysiol. 91:571-575
100. Kuo JJ, Siddique T, Fu R, Heckman CJ. 2005. Increased persistent Na(+) current and its effect on excitability in motoneurones cultured from mutant SOD1 mice. J. Physiol. 563:843-854
101. LandmesserL. 1978. The distribution ofmotoneurones supplying chick hind limbmuscles. J. Physiol. 284:371-389
102. Larsson L, Ansved T. 1995. Effects of ageing on the motor unit. Prog. Neurobiol. 45:397-458
103. Laslo P, Lipski J,Nicholson LF, Miles GB, Funk GD. 2000. Calcium binding proteins in motoneurons at low and high risk for degeneration in ALS. Neuroreport 11:3305-3308
104. Lee RH, Heckman CJ. 1998a. Bistability in spinal motoneurons in vivo: systematic variations in persistent inward currents. J. Neurophysiol. 80:583-593
105. Lee RH, Heckman CJ. 1998b. Bistability in spinal motoneurons in vivo: systematic variations in rhythmic firing patterns. J. Neurophysiol. 80:572-582
106. Ligon LA, LaMonte BH,Wallace KE,Weber N, Kalb RG,Holzbaur EL. 2005. Mutant superoxide dismutase disrupts cytoplasmic dynein in motor neurons. Neuroreport 16:533-536
107. Lin JH, Saito T, Anderson DJ, Lance-Jones C, Jessell TM, Arber S. 1998. Functionally related motor neuron pool and muscle sensory afferent subtypes defined by coordinate ETS gene expression. Cell 95:393-407
108. Livet J, Sigrist M, Stroebel S, De Paola V, Price SR, et al. 2002. ETS gene Pea3 controls the central position and terminal arborization of specific motor neuron pools. Neuron 35:877-892
109. Locatelli F, Corti S, Papadimitriou D, Fortunato F, Del Bo R, et al. 2007. Fas small interfering RNA reduces motoneuron death in amyotrophic lateral sclerosis mice. Ann. Neurol. 62:81-92
110. Mandai K, Guo T, St Hillaire C, Meabon JS, Kanning KC, et al. 2009. LIG family receptor tyrosine kinaseassociated proteins modulate growth factor signals during neural development. Neuron 63:614-627
111. Mannen T. 2000. Neuropathological findings of Onuf's nucleus and its significance. Neuropathology 20(Suppl.):S30-33
112. Martin LJ, Liu Z, Chen K, Price AC, Pan Y, et al. 2007. Motor neuron degeneration in amyotrophic lateral sclerosis mutant superoxide dismutase-1 transgenic mice: mechanisms of mitochondriopathy and cell death. J. Comp. Neurol. 500:20-46
113. McComas AJ. 1991. Invited review: motor unit estimation: methods, results, and present status. Muscle Nerve 14:585-597
114. Mendell LM. 2005. The size principle: a rule describing the recruitment of motoneurons. J. Neurophysiol. 93:3024-3026
115. Mentis GZ, Sumner CJ, O'Donovan MJ. 2008. Altered synaptic input and excitability of motor neurons in SMA mice. Progr. No.643.22. Neuroscience Meeting Planner. Washington, DC: Soc. Neurosci. http://www.sfn.org/am2008/
116. Mi R, Chen W, Hoke A. 2007. Pleiotrophin is a neurotrophic factor for spinal motor neurons. Proc. Natl. Acad. Sci. USA 104:4664-4669
117. Mitsumoto H, Przedborski S, Gordon PH. 2006. Amyotrophic Lateral Sclerosis. Boca Raton, FL: Taylor & Francis. xxvi, 830 pp.
118. Monani UR. 2005. Spinal muscular atrophy: a deficiency in a ubiquitous protein; a motor neuron-specific disease. Neuron 48:885-896
119. Moore MW, Klein RD, Farinas I, Sauer H, Armanini M, et al. 1996. Renal and neuronal abnormalities in mice lacking GDNF. Nature 382:76-79
120. Mourelatos Z, GonatasNK, Stieber A,GurneyME, Dal Canto MC. 1996. TheGolgi apparatus of spinal cord motor neurons in transgenic mice expressing mutant Cu,Zn superoxide dismutase becomes fragmented in early, preclinical stages of the disease. Proc. Natl. Acad. Sci. USA 93:5472-5477
121. NayakMS, Kim YS, GoldmanM, Keirstead HS, Kerr DA. 2006. Cellular therapies in motor neuron diseases. Biochim. Biophys. Acta 1762:1128-1138
122. Nguyen QT, Parsadanian AS, SniderWD, Lichtman JW. 1998. Hyperinnervation of neuromuscular junctions caused by GDNF overexpression in muscle. Science 279:1725-1729
123. Nikolaev A,McLaughlin T, O'Leary DD, Tessier-Lavigne M. 2009. APP binds DR6 to trigger axon pruning and neuron death via distinct caspases. Nature 457:981-989
124. Nishitoh H, Kadowaki H, Nagai A, Maruyama T, Yokota T, et al. 2008. ALS-linked mutant SOD1 induces ER stress- and ASK1-dependent motor neuron death by targeting Derlin-1. Genes Dev. 22:1451-1464
125. Obal I, Engelhardt JI, Siklos L. 2006. Axotomy induces contrasting changes in calcium and calcium-binding proteins in oculomotor and hypoglossal nuclei of Balb/c mice. J. Comp. Neurol. 499:17-32
126. Oppenheim RW. 1991. Cell death during development of the nervous system. Annu. Rev. Neurosci. 14:453-501
127. Oppenheim RW.1996. Neurotrophic survival molecules for motoneurons: an embarrassment of riches. Neuron 17:195-197
128. Oppenheim RW, Blomgren K, Ethell DW, KoikeM, Komatsu M, et al. 2008. Developing postmitotic mammalian neurons in vivo lacking Apaf-1 undergo programmed cell death by a caspase-independent, nonapoptotic pathway involving autophagy. J. Neurosci. 28:1490-1497
129. Oppenheim RW, Cole T, Prevette D. 1989. Early regional variations in motoneuron numbers arise by differential proliferation in the chick embryo spinal cord. Dev. Biol. 133:468-474
130. Oppenheim RW, Flavell RA, Vinsant S, Prevette D, Kuan CY, Rakic P. 2001. Programmed cell death of developing mammalian neurons after genetic deletion of caspases. J. Neurosci. 21:4752-4760
131. Oppenheim RW, Houenou LJ, Parsadanian AS, Prevette D, Snider WD, Shen L. 2000. Glial cell linederived neurotrophic factor and developing mammalian motoneurons: regulation of programmed cell death among motoneuron subtypes. J. Neurosci. 20:5001-5011
132. Papadimitriou D, Le Verche V, Jacquier A, Ikiz B, Przedborski S, Re DB. 2010. Inflammation in ALS and SMA: sorting out the good from the evil. Neurobiol. Dis. 37:493-502
133. Pasinelli P, Brown RH. 2006. Molecular biology of amyotrophic lateral sclerosis: insights from genetics. Nat. Rev. Neurosci. 7:710-723
134. Pasinelli P, Houseweart MK, Brown RH Jr, Cleveland DW. 2000. Caspase-1 and -3 are sequentially activated in motor neuron death in Cu,Zn superoxide dismutase-mediated familial amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. USA 97:13901-13906
135. Pecho-Vrieseling E, Sigrist M, Yoshida Y, Jessell TM, Arber S. 2009. Specificity of sensory-motor connections encoded by Sema3e-Plxnd1 recognition. Nature 459:842-846
136. Pennica D, Arce V, Swanson TA, Vejsada R, Pollock RA, et al. 1996. Cardiotrophin-1, a cytokine present in embryonic muscle, supports long-term survival of spinal motoneurons. Neuron 17:63-74
137. Perlson E, Jeong GB, Ross JL, Dixit R, Wallace KE, et al. 2009. A switch in retrograde signaling from survival to stress in rapid-onset neurodegeneration. J. Neurosci. 29:9903-9917
138. Pettmann B, Henderson CE. 1998. Neuronal cell death. Neuron 20:633-647
139. Piehl F, Arvidsson U, Hokfelt T, Cullheim S. 1993. Calcitonin gene-related peptide-like immunoreactivity in motoneuron pools innervating different hind limb muscles in the rat. Exp. Brain Res. 96:291-303
140. Plachta N, Annaheim C, Bissiere S, Lin S, Ruegg M, et al. 2007. Identification of a lectin causing the degeneration of neuronal processes using engineered embryonic stem cells. Nat. Neurosci. 10:712-719
141. Pun S, Santos AF, Saxena S, Xu L, Caroni P. 2006. Selective vulnerability and pruning of phasic motoneuron axons in motoneuron disease alleviated by CNTF. Nat. Neurosci. 9:408-419
142. Radunovic A, Mitsumoto H, Leigh PN. 2007. Clinical care of patients with amyotrophic lateral sclerosis. Lancet Neurol. 6:913-925
143. Rafuse VF, Milner LD, Landmesser LT. 1996. Selective innervation of fast and slow muscle regions during early chick neuromuscular development. J. Neurosci. 16:6864-6877
144. Raoul C, Buhler E, Sadeghi C, Jacquier A, Aebischer P, et al. 2006. Chronic activation in presymptomatic amyotrophic lateral sclerosis (ALS) mice of a feedback loop involving Fas, Daxx, and FasL. Proc. Natl. Acad. Sci. USA 103:6007-6012
145. Raoul C, Estevez AG, NishimuneH,ClevelandDW,deLapeyriere O, et al. 2002. Motoneuron death triggered by a specific pathway downstream of Fas. potentiation by ALS-linked SOD1 mutations. Neuron 35:1067-1083
146. Rekling JC, Funk GD, Bayliss DA, Dong XW, Feldman JL. 2000. Synaptic control ofmotoneuronal excitability. Physiol. Rev. 80:767-852
147. Romanes GJ. 1951. The motor cell columns of the lumbo-sacral spinal cord of the cat. J. Comp. Neurol. 94:313-363
148. Saito M, Tomonaga M, Narabayashi H. 1978. Histochemical study of the muscle spindles in parkinsonism, motor neuron disease and myasthenia. An examination of the pathological fusimotor endings by the acetylcholinesterase technic. J. Neurol. 219:261-271
149. Sasaki S, Warita H, Komori T, Murakami T, Abe K, Iwata M. 2006. Parvalbumin and calbindin D-28k immunoreactivity in transgenic mice with a G93A mutant SOD1 gene. Brain Res. 1083:196-203
150. Saxena S, Cabuy E, Caroni P. 2009.Arole for motoneuron subtype-selectiveERstress in disease manifestations of FALS mice. Nat. Neurosci. 12:627-636
151. Schaefer AM, Sanes JR, Lichtman JW. 2005. A compensatory subpopulation of motor neurons in a mouse model of amyotrophic lateral sclerosis. J. Comp. Neurol. 490:209-219
152. Schroder HD, Reske-Nielsen E. 1984. Preservation of the nucleus X-pelvic floor motosystem in amyotrophic lateral sclerosis. Clin. Neuropathol. 3:210-216
153. Shneider NA, Brown MN, Smith CA, Pickel J, Alvarez FJ. 2009. Gamma motor neurons express distinct genetic markers at birth and require muscle spindle-derived GDNF for postnatal survival. Neural Dev. 4:42
154. Simon M, Destombes J, Horcholle-Bossavit G, Thiesson D. 1996. Postnatal development of alpha- and gamma-peroneal motoneurons in kittens: an ultrastructural study. Neurosci Res. 25:77-89
155. Strelau J, Strzelczyk A, Rusu P, Bendner G, Wiese S, et al. 2009. Progressive postnatal motoneuron loss in mice lacking GDF-15. J. Neurosci. 29:13640-13648
156. Sturrock RR. 1988. Loss of neurons from the motor nucleus of the facial nerve in the ageing mouse brain. J. Anat. 160:189-194
157. Sturrock RR. 1991. Stability of motor neuron number in the oculomotor and trochlear nuclei of the ageing mouse brain. J. Anat. 174:125-129
158. Sumi H, Nagano S, Fujimura H, Kato S, Sakoda S. 2006. Inverse correlation between the formation of mitochondria-derived vacuoles and Lewy-body-like hyaline inclusions in G93A superoxide-dismutasetransgenic mice. Acta Neuropathol. 112:52-63
159. Sun W, Gould TW, Vinsant S, Prevette D, Oppenheim RW. 2003. Neuromuscular development after the prevention of naturally occurring neuronal death by Bax deletion. J. Neurosci. 23:7298-7310
160. Sung JH, Mastri AR. 1980. Spinal autonomic neurons in Werdnig-Hoffmann disease, mannosidosis, and Hurler's syndrome: distribution of autonomic neurons in the sacral spinal cord. J. Neuropathol. Exp. Neurol. 39:441-451
161. Swash M, Fox KP. 1974. The pathology of the human muscle spindle: effect of denervation. J. Neurol. Sci. 22:1-24
162. Swash M, Leader M, Brown A, Swettenham KW. 1986. Focal loss of anterior horn cells in the cervical cord in motor neuron disease. Brain 109(Pt. 5):939-952
163. Traynor BJ, Bruijn L, Conwit R, Beal F, O'Neill G, et al. 2006. Neuroprotective agents for clinical trials in ALS: a systematic assessment. Neurology 67:20-27
164. Tu PH, Raju P, Robinson KA, Gurney ME, Trojanowski JQ, Lee VM. 1996. Transgenic mice carrying a human mutant superoxide dismutase transgene develop neuronal cytoskeletal pathology resembling human amyotrophic lateral sclerosis lesions. Proc. Natl. Acad. Sci. USA 93:3155-3160
165. Turner BJ,Talbot K. 2008. Transgenics, toxicity and therapeutics in rodent models of mutant SOD1-mediated familial ALS. Prog. Neurobiol. 85:94-134
166. Valdmanis PN, Rouleau GA. 2008. Genetics of familial amyotrophic lateral sclerosis. Neurology 70:144-152
167. Van Damme P, Van Hoecke A, Lambrechts D, Vanacker P, Bogaert E, et al. 2008. Progranulin functions as a neurotrophic factor to regulate neurite outgrowth and enhance neuronal survival. J. Cell Biol. 181:37-41
168. Van Den Bosch L, Storkebaum E, Vleminckx V, Moons L, Vanopdenbosch L, et al. 2004. Effects of vascular endothelial growth factor (VEGF) on motor neuron degeneration. Neurobiol. Dis. 17:21-28
169. Van Den Bosch L, Van Damme P, Bogaert E, RobberechtW. 2006. The role of excitotoxicity in the pathogenesis of amyotrophic lateral sclerosis. Biochim. Biophys. Acta 1762:1068-1082
170. Vanderhorst VG, Holstege G. 1997. Organization of lumbosacral motoneuronal cell groups innervating hindlimb, pelvic floor, and axial muscles in the cat. J. Comp. Neurol. 382:46-76
171. Vandervoort AA. 2002. Aging of the human neuromuscular system. Muscle Nerve 25:17-25
172. van Zundert B, Peuscher MH, Hynynen M, Chen A, Neve RL, et al. 2008. Neonatal neuronal circuitry shows hyperexcitable disturbance in a mouse model of the adult-onset neurodegenerative disease amyotrophic lateral sclerosis. J. Neurosci. 28:10864-10874
173. Vejsada R, Tseng JL, Lindsay RM, Acheson A, Aebischer P, Kato AC. 1998. Synergistic but transient rescue effects of BDNF and GDNF on axotomized neonatal motoneurons. Neuroscience 84:129-139
174. Veldink JH, Bar PR, Joosten EA, Otten M, Wokke JH, van den Berg LH. 2003. Sexual differences in onset of disease and response to exercise in a transgenic model of ALS. Neuromuscul. Disord. 13:737-743
175. Vlug AS, Teuling E, Haasdijk ED, French P, Hoogenraad CC, Jaarsma D. 2005. ATF3 expression precedes death of spinal motoneurons in amyotrophic lateral sclerosis-SOD1 transgenic mice and correlates with c-Jun phosphorylation, CHOP expression, somato-dendritic ubiquitination and Golgi fragmentation. Eur. J. Neurosci. 22:1881-1894
176. Vrieseling E, Arber S. 2006. Target-induced transcriptional control of dendritic patterning and connectivity in motor neurons by the ETS gene Pea3. Cell 127:1439-1452
177. Vukosavic S, Stefanis L, Jackson-Lewis V, Guegan C, Romero N, et al.
178. Wang P, Yang G, Mosier DR, Chang P, Zaidi T, et al. 2005a. Defective neuromuscular synapses in mice lacking amyloid precursor protein (APP) and APP-Like protein 2. J. Neurosci. 25:1219-1225
179. Wang PY, Koishi K, McGeachie AB, Kimber M, Maclaughlin DT, et al. 2005b. Mullerian inhibiting substance acts as a motor neuron survival factor in vitro. Proc. Natl. Acad. Sci. USA 102:16421-16425
180. Warita H, Manabe Y, Murakami T, Shiote M, Shiro Y, et al. 2002. Tardive decrease of astrocytic glutamate transporter protein in transgenic mice with ALS-linked mutant SOD1. Neurol. Res. 24:577-581
181. Westbury DR. 1982. A comparison of the structures of alpha and gamma-spinal motoneurones of the cat. J. Physiol. 325:79-91
182. Whitehead J, Keller-Peck C, Kucera J, Tourtellotte WG. 2005. Glial cell-line derived neurotrophic factordependent fusimotor neuron survival during development. Mech. Dev. 122:27-41
183. Williams AH, Valdez G, Moresi V, Qi X, McAnally J, et al. 2009. MicroRNA-206 delays ALS progression and promotes regeneration of neuromuscular synapses in mice. Science 326:1549-1554
184. Wong PC, Cai H, Borchelt DR, Price DL. 2002. Genetically engineered mouse models of neurodegenerative diseases. Nat. Neurosci. 5:633-639
185. Wooley CM, Sher RB, Kale A, FrankelWN, Cox GA, Seburn KL. 2005. Gait analysis detects early changes in transgenic SOD1(G93A) mice. Muscle Nerve 32:43-50
186. Wootz H, Hansson I, Korhonen L, Napankangas U, Lindholm D. 2004. Caspase-12 cleavage and increased oxidative stress during motoneuron degeneration in transgenic mouse model of ALS. Biochem. Biophys. Res. Commun. 322:281-286
187. Wright DE, Snider WD. 1996. Focal expression of glial cell line-derived neurotrophic factor in developing mouse limb bud. Cell Tissue Res. 286:209-217
188. Yang YS, Harel NY, Strittmatter SM. 2009. Reticulon-4A (Nogo-A) redistributes protein disulfide isomerase to protect mice from SOD1-dependent amyotrophic lateral sclerosis. J. Neurosci. 29:13850-13859
189. Yoshikawa M, Vinsant S, Mansfield CM, Moreno RJ, Gifondorwa DJ, et al. 2009. Identification of changes in muscle, neuromuscular junctions and spinal cord at early presymptomatic stages in the mutant SOD1 mouse model of ALS may provide novel insight for diagnosis and treatment development. Progr. No.632.5. 2009 Neuroscience Meeting Planner. Chicago, IL: Soc. Neurosci. http://www.sfn.org/am2009/
190. Zhang B, Tu P, Abtahian F, Trojanowski JQ, Lee VM. 1997. Neurofilaments and orthograde transport are reduced in ventral root axons of transgenic mice that express human SOD1 with a G93A mutation. J. Cell Biol. 139:1307-1315
191. Zhong Z, Deane R, Ali Z, ParisiM, Shapovalov Y, et al. 2008. ALS-causing SOD1 mutants generate vascular changes prior to motor neuron degeneration. Nat. Neurosci. 11:420-422